Utilisation of Human Pharmacology Studies with Biomarkers for New Drug Applications in Japan

ISSN： 1174-5886

Source： Drugs in R&D, Vol.6, Iss.1, 2005-01, pp. : 21-34

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetic and Pharmacodynamic Data to be Derived from Early-Phase Drug Development: Designing Informative Human Pharmacology Studies

By Cohen Adam

Clinical Pharmacokinetics, Vol. 47, Iss. 6, 2008-01 ,pp. : 373-381

Adis International

Access to resources Recommend Favorite

Human Disease and Drug Pharmacology, Complex as Real Life

Current Medicinal Chemistry, Vol. 20, Iss. 13, 2013-04 ,pp. : 1623-1634

Bentham Science Publishers

Access to resources Recommend Favorite

Development of a new engineering-based capsule for human drug absorption studies

By Wilding I. Hirst P. Connor A.

Pharmaceutical Science & Technology Today, Vol. 3, Iss. 11, 2000-11 ,pp. : 385-392

Elsevier

Access to resources Recommend Favorite

The Japan PDMA will require pharmaceutical companies to include risk management plans in all applications, for new drug or biosimilar products

Reactions Weekly, Vol. 1, Iss. 1431, 2012-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

The Applications of Biomarkers in Early Clinical Drug Development to Improve Decision-Making Processes

Current Clinical Pharmacology, Vol. 1, Iss. 2, 2006-05 ,pp. : 185-191

Bentham Science Publishers

Access to resources Recommend Favorite